Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) General Information

Description

Preclinical research stage assets including intellectual property and prodrug technologies located in Umea, Sweden.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Umea
  • Sweden
Primary Industry
Buildings and Property
Other Industries
Other Healthcare
Acquirer
Corporate Office
  • Umea
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden)‘s full profile, request access.

Request a free trial

Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden)‘s full profile, request access.

Request a free trial

Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) FAQs

  • Where is Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) headquartered?

    Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) is headquartered in Umea, Sweden.

  • What industry is Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) in?

    Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden)’s primary industry is Buildings and Property.

  • Is Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) a private or public company?

    Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) is a Private company.

  • What is Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden)’s current revenue?

    The current revenue for Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) is .

  • Who are Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden)’s investors?

    Novadex Pharmaceuticals has invested in Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden).

  • When was Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) acquired?

    Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) was acquired on 05-Sep-2012.

  • Who acquired Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden)?

    Novadex Pharmaceuticals (Preclinical Research Stage Assets in Umea, Sweden) was acquired by Medivir.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process